4UBI:XETRA:XETRA-UBS (Irl) ETF plc - MSCI USA Socially Responsible UCITS ETF (USD) A-acc (EUR)

ETF | Others |

Last Closing

USD 16.258

Change

0.00 (0.00)%

Market Cap

USD 0.37B

Volume

0.03M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.02 (+0.04%)

USD 448.39B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.01 (+0.04%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.07 (+0.26%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.11 (-0.46%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

+0.50 (+0.33%)

USD 126.93B
JARI:XETRA Amundi Index Solutions - Amund..

+0.04 (+0.08%)

USD 102.57B
8R80:XETRA Amundi Index Solutions - Amund..

+0.08 (+0.06%)

USD 102.14B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.01 (+0.02%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-2.28 (-0.44%)

USD 80.38B

ETFs Containing 4UBI:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.89% 63% D 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.89% 63% D 63% D
Trailing 12 Months  
Capital Gain 29.32% 88% B+ 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 29.32% 88% B+ 86% B+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.91% 64% D 62% D
Dividend Return 6.91% 63% D 60% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.11% 57% F 66% D+
Risk Adjusted Return 62.20% 78% C+ 79% B-
Market Capitalization 0.37B 62% D 55% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike